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Abstract 
Lipids are a large and highly diverse family of biomolecules, which play essential structural, 
storage and signalling roles in cells and tissues. Although traditional mass spectrometry (MS) 
approaches used in lipidomics are highly sensitive and selective, lipid analysis remains 
challenging due to the chemical diversity of lipid structures, multiple isobaric species and 
incomplete separation using many forms of chromatography. Ion mobility (IM) separates ions 
in the gas phase based on their physicochemical properties. Addition of IM to the traditional 
lipidomic workflow both enhances separation of complex lipid mixtures, beneficial for lipid 
identification, and improves isomer resolution. Herein, we discuss the recent developments in 
IM-MS for lipidomics. 
 
Graphical Abstract 
  
Highlights  
● We review the current advantages of IM-MS spectrometry in lipidomics. 
● Collision Cross-Section (CCS) values enhance confidence in lipid identification. 
● IM separation coupled with fragmentation of precursor ions results in cleaner product 
ion spectra, allowing improved data interpretation. 
● IM-MS improves separation of isomeric lipids.  
 
Abbreviations/Glossary 
BMP  bis(monoacylglycerol) phosphate 
CCS  Collision Cross-Section 
CE  cholesteryl ester 
DAG  diacylglycerides 
FA  fatty acid 
GL  glycerolipid 
GP  glycerophospholipid 
IM  ion mobility 
LC  liquid chromatography 
Lyso-PL lyso-phospholipid 
MS  mass spectrometry 
PC  phosphatidylcholine   
PE  phosphatidylethanolamine 
PG  phosphatidylglycerol 
PI  phosphatidylinositol 
PS  phosphatidylserine 
SM  sphingomyelin 
TAG  triacylglycerides 
 
Introduction 
Lipids are a highly diverse group of biomolecules comprising several complex lipid categories 
(detailed in Figure 1) which form an enormous network of structural, storage and signalling 
molecules within living organisms. Online databases such as LipidBlast [1], and LIPID MAPS 
[2] attempt to cover this large amount of information. However, the actual number of 
structurally distinct lipids is unknown. Today, the largest database is the LIPID MAPS Structure 
Database, which contains nearly 41,000 unique biologically relevant lipid structures, out of 
which approximately half is manually curated and half computationally generated 
(http://www.lipidmaps.org/data/structure/index.html, last accessed 25/07/2017). 
 
Figure 1: Fatty acid derived lipid categories. Fatty acids (FAs), which contain 2-40 carbon atoms and different 
degrees of unsaturation, are the smallest building blocks for much more complex lipid categories. These categories 
include sphingolipids, glycerolipids (GLs), glycerophospholipids (GPs), sterols, prenols, saccharolipids, and 
polyketides. Each category can be further divided into classes such as GPs into phosphatidylglycerols (PGs), 
phosphatidylethanolamines (PEs), phosphatidylcholines (PCs), phosphatidylserines (PSs), and 
phosphatidylinositols (PIs) depending on the head group (indicated with X). 
 
The vast chemical space covered by the various lipid categories, along with the structural 
similarities within the same class, represents a significant analytical challenge in lipidomic 
studies, aiming to profile the entire lipid content (lipidome) of the studied samples. Currently, 
high-resolution mass spectrometry (MS) approaches either alone (shotgun MS) or coupled 
with liquid chromatography (LC/MS) are commonly used. However, insufficient separation of 
isomeric and isobaric species, very common in complex biological samples, is a major 
challenge. Therefore, further analytical separation methods are required to resolve isobaric 
lipid species, uncover the isomeric distribution of lipids, and to improve the confidence in lipid 
identification in biological samples.  
Ion mobility (IM) is a gas-phase technique allowing the separation of ions based on their 
mobility through an inert gas (typically helium or nitrogen) under the influence of an electric 
field [3–6]. A number of different technologies in which IM is coupled with MS (IM-MS) have 
been developed, including the commercially available (1) Drift Time Ion Mobility Spectrometry 
(DTIMS), developed by Agilent Technologies [7], (2) Field Asymmetric Ion Mobility 
Spectrometry/Differential Mobility Spectrometry (FAIMS/DMS) approach provided by AB 
Sciex [8,9], (3) Travelling Wave Ion Mobility Spectrometry (TWIMS) developed by Waters 
[8,10], and (4) Trapped Ion Mobility Spectrometry (TIMS) developed by Bruker [11–13] . A 
detailed description of the theoretical concepts behind ion separation in these different 
technologies is not within the scope and space of this brief review, and hence we refer the 
reader to recent reviews in the field [4–6]. IM-MS has been shown to provide significant 
analytical improvements for a variety of chemical classes. Compared to MS only, using IM-
MS as additional separation reduces interfering signals in the gas phase, thus increasing 
spectral clarity, enhancing peak capacity, and improving both selectivity and sensitivity [14–
19]. In addition, the Collision Cross-Section (CCS), a physicochemical descriptor correlated to 
shape, size and charge of ions, can be calculated with most commercially available 
instruments by considering the experimental conditions and the observed mobility of ions. 
Both CCS values and accurate mass are highly reproducible (< 2%, < 5 ppm, respectively) 
[17,19,20] and can be used to discriminate closely related species by both size and mass. In 
addition, coupling LC to IM-MS [6] allows compound characterisation in multiple dimensions, 
making LC/IM-MS a promising approach for the comprehensive analysis of complex lipid 
mixtures [17,19]. 
Due to the emerging developments in both hardware and software, IM-MS has recently been 
implemented in a variety of lipidomic workflows, which are reviewed in the following sections.  
Improved lipid identification by IM-MS 
Currently, compounds discovered in a lipidomic workflow are putatively identified based on 
accurate mass match with online databases such as LIPID MAPS or LipidBlast. However, as 
accurate mass only provides the molecular formula, it could correspond to a number of species 
belonging to different lipid classes. Therefore, further information about the compound’s 
physicochemical characteristics are required to allow a more accurate identification. It has 
been shown that the CCS values of FAs and PCs are highly correlated with both the lipid chain 
length and the degree of unsaturation [21–23] (Figure 2 A and B). In particular, larger CCS 
values are found for saturated species, whose acyl chains extend under the electric field, while 
unsaturated bonds confer a bent structure in the acyl chain resulting in smaller CCS values 
[21,22]. The CCS is influenced not only by the degree of saturation, but more generally by the 
structural characteristics of compounds. Thus, different lipid categories, such as GPs and 
sphingolipids, have distinct mobility behaviours by which they can be separated. This allows 
a more selective analysis of lipids belonging to different categories but sharing an identical 
accurate mass [24]. In addition, the distinct mobility trends observed not only between lipid 
categories but also among different biomolecular families (such as lipids, peptides and 
oligonucleotides) improve data interpretation in imaging MS [19,25–32]. In this technique, 
lipids are analysed directly from tissue slices without additional extraction and/or purification 
steps, allowing simultaneous CCS evaluation and lipid localisation in tissue [33]. Similarly, 
different lipid classes belonging to the same category can be separated by mobility based on 
their head groups (shown for PEs and PC in Figure 2 C); however, separation is less efficient 
than between lipid categories, with some overlapping CCS values between certain species 
[19,26]. Overall, these lipid category/class specific mobility behaviours decrease the false 
discovery rate providing a higher degree of confidence in lipid identification [17,22,24,26,34]. 
 Figure 2. Improved identification of lipids by IM-MS. The CCS values of fatty acids increase with both (A) 
number of double bonds (C16-C20 indicates the number of carbon atoms and x the number of double bonds) and 
(B) lipid chain length. (C) PEs and PCs are mobility separated based on their head group using a DTIMS-MS 
instrument.  
In order to validate experimentally obtained CCS values, several research groups have 
developed their own CCS databases by analysing synthetic lipid standards [17,19,35].  
However, due to the limited number of commercially available standards, in silico CCS 
determination may represent a promising approach to cover the lipidome of complex biological 
matrices, as demonstrated for lipids and other biomolecules [36–40]. 
Traditionally, lipids are identified using either targeted or untargeted fragmentation of 
precursor ions to obtain diagnostic product ions in high-resolution spectra [41–46]. The 
addition of IM to targeted  workflows, in which precursor ion masses are selected for 
fragmentation, has been shown to reduce background noise, simplifying interpretation of the 
spectra and improving the overall detection limits in lipid mixtures [14,16,30]. This is very 
important when analysing low abundant but biologically relevant species. On the other hand, 
targeted methods may struggle with poor duty cycles and decreased sensitivity when too many 
ion masses are fragmented. Untargeted fragmentation can overcome these sensitivity issues 
as no precursor ion masses are selected. However, data interpretation is challenging due to 
presence of multiple product ion masses deriving from co-eluting species in the same 
spectrum. This is especially true for lipids, as their fragments share a high degree of similarity 
[47]. It has been demonstrated that addition of IM to untargeted lipidomics allows mobility-
alignment of fragment ions to their precursors when fragmentation takes place following 
mobility separation [48–51] (Figure 3).In contrast, fragmentation prior to IM separation allows 
CCS evaluation of diagnostic product ions as an additional identifying factor [52–54]. 
Therefore, both approaches improve data interpretation and enhance lipid identification in 
untargeted workflows. 
 
 Figure 3:  Ion mobility separation of co-eluting lipids and their product ions. (A) Chromatographic 
separation of a complex mixture of lipids such as tissue extracts containing lyso-phospholipids (lyso-PLs), 
glycerophospholipids (GPs), sphingomyelins (SMs), triacylglycerides (TAGs), diacylglycerides (DAGs) and 
cholesteryl-esters (CEs) with the extracted ion chromatogram of insufficiently separated lipids species magnified 
in yellow, blue, and green. These species can be separated by (B) ion mobility and (C) accurate mass. For lipid 
identification collision-induced fragmentation is applied. However, untargeted fragmentation of all precursor ions 
present in a sample results in a mix of both precursor (solid) and product (dashed) ion (D) mobilities in the 
mobilogram and (E) ion masses in the product ion spectrum. As IM separation occurs before fragmentation, 
product ions can be mobility-aligned to their precursor ions consequently improving interpretation of product ion 
spectra (F). In addition, identical product ions deriving from different precursor ions (such as red deriving from 
green and yellow) can be assigned to their precursors in correct proportions (marked in red). 
  
 
Isomer separation 
One of the major challenges in lipid analysis is isomer separation, with regio- (such as sn1 or 
sn2 for GPs), positional (position of double bond), or geometric (cis/trans conformation of the 
double bond, also known as Z/E) isomers commonly found in complex lipid mixtures (
 
Figure 4). Although LC can separate some isomeric compounds, several will co-elute and 
exhibit identical fragmentation spectra, making their identification difficult. IM can improve 
separation of isobaric and isomeric lipids due to differences in their structure and shape 
[24,55–57]. However, all three dimensions of LC, IM and MS are needed to target isomer 
separation which still may not be complete [22,49,58], although it can be enhanced by the use 
of different inert gases in the mobility chamber [24,55]. 
The conformational differences between geometrical isomers, and in particular the curled 
structure caused by a cis- double bond in contrast to a more open conformation conferred by 
trans geometry, allows separation between cis and trans isomers of GPs [22]. In addition, cis-
unsaturated positional isomers of FAs could be resolved, while their equivalents containing 
trans-double bonds could not be distinguished due to smaller differences in shape caused by 
the trans geometry compared to cis [22]. Comparably, a double bond closer to the head group 
of GPs causes a larger structure than when positioned further down the acyl chain, allowing 
separation of PC positional isomers [59]. In contrast, positional isomers of mono-unsaturated 
FAs could only be separated when injected individually, while their mixtures could not be 
resolved due to only minor differences among the isomers conformations [23]. Separation of 
GP regioisomers was observed in targeted [48], multidimensional (IMS3-MS) [34] approaches, 
with a more elongated three-dimensional conformation observed when the longer FA chain is 
linked to the sn1 position [22]. Interestingly, the opposite holds for lysoPC (which only have a 
single acyl chain attached to either sn1 or sn2 position of the GP backbone), where a FA in 
sn2 position results in a larger cross-section for the ion [22].  
The separation of isomers whose spatial conformations are too similar can be enhanced with 
several strategies, such as using instruments with a higher IM resolving power [50,55,60]. 
Indeed, on a lower resolution instrument the two structural isomers PG and 
bis(monoacylglycerol) phosphate (BMP) could be distinguished only following evaluation of 
their fragmentation pattern [61], while their separation as native ions was possible by 
increasing the IM resolving power [22].  However, the choice of commercially available IM-MS 
instruments offering a high resolving power today is limited [50]. To overcome this deficiency, 
derivatization can be used to increase the shape differences between isomers and was shown 
to successfully resolve synthetically generated steroid isoforms [62]. Similarly, the formation 
of adducts with alkali ions can enhance isomers separation thanks to the differences in 
coordination geometries, as demonstrated for steroid epimers, ceramide stereoisomers, and 
diastereoisomeric forms of sphingosine [22,59,63]. Furthermore, interaction of alkali ions with 
the double bond, in contrast to protonation which happens in the head group, can increase 
the separation between sodiated and potassiated adducts of PC geometrical and regioisomers 
[64]. Likewise, the ability of silver to bind both lone pairs of electrons from heteroatoms and π 
electrons of the double bond allowed resolution of PC  as well as GL isomers [65,66]. Another 
approach to assign double bond positions in complex lipids and distinguish GL isomers is 
ozone-induced dissociation (OzID) [67]. Although not the main focus of their study, Poad and 
co-workers observed mobility separation between precursor and OzID product ions, indicating 
OzID coupled with IM as a promising approach to gain further understanding into lipid 
structures. 
 
 
 
Figure 4: Isomeric structures of glycerophospholipids. Glycerophospholipids (GPs) consist of a polar head 
group (glycerol, choline, ethanolamine, inositol, or serine indicated as “x”) and two fatty acyl groups at sn1 (16:0) 
and sn2 (18:1 (9Z)) position forming the GP tail. Three types of isomers are possible: a regioisomer presenting the 
fatty acyl chains in inverted positions; a positional isomer, containing the double bond in different position (C6 
instead of C9), and a geometric isomer, whose double bond is in trans (E) conformation. 
 
 
Conclusion 
The chemical complexity of lipids makes highly sensitive and selective analytical tools crucial 
for their analysis in complex mixtures such as extracts of biological tissues. Recent technical 
developments in both hardware and software enabled researchers to implement IM-MS into 
their analytical workflows with four major improvements in lipidomic analysis. First, IM-MS 
improves separation of lipids in complex mixtures, crucial to resolving isobaric species in 
biological samples. Second, IM improves the spectral clarity of product ion spectra derived 
from fragmentation experiments. This is important in both lipid identification and structural 
elucidation, which are challenging tasks due to isomeric nature of many lipid species. On the 
other hand, analysis of product ion spectra derived from untargeted fragmentation acquisitions 
remains challenging due to the required powerful processing tools. Third, IM improves 
separation of isomeric lipids. However, to completely uncover the isomeric distribution in 
complex lipid mixtures, a higher resolving power than is commercially available today may be 
required. Last, CCS values obtained from IM-MS analysis effectively increase confidence in 
lipid identification. However, validation of CCS values is restricted to the limited number of 
commercially available lipid standards. Therefore, in silico CCS prediction is an important tool 
to improve identification efficiency in lipidomics. Concluding, IM-MS is a promising analytical 
tool for lipidomic studies that has the potential of providing new insights into lipid biology. 
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